Product
Zr-Df-crefmirlimab
1 clinical trial
2 indications
Indication
Multiple SclerosisClinical trial
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy: A Pilot StudyStatus: Recruiting, Estimated PCD: 2024-06-30